Business

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced today that it has launched the MyoVista InsightsTM platform and related early adopter program for select reference sites. MyoVista Insights is a cloud-native next-generation ECG Management System designed

articleHeartsciences Inc.May 1, 20255/company/heart-test-laboratories-inc-common-stock/news/heartsciences-announces-launch-myovista-insights-130000099
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

About this update from Heartsciences Inc.

[{"type":"image","alt":"Heart Test Laboratories, Inc.","displaySize":"","headline":null,"caption":"Heart Test Laboratories, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":271,"height":58,"url":"https://media.zenfs.com/en/globenewswire.com/bb8c6c7931166e53de866ed1f7dbdc1d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TQBZp3ueg1_7du_2jEqWig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/bb8c6c7931166e53de866ed1f7dbdc1d","width":271,"height":58}},"lazy":false},{"type":"text","content":"Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced today that it has launched the MyoVista InsightsTM platform and related early adopter program for select reference sites.","length":447,"tagName":"p"},{"type":"text","content":"MyoVista Insights is a cloud-native next-generation ECG Management System designed to enhance both clinical decision-making and healthcare IT efficiency. It will integrate company developed and third-party AI-ECG algorithms as part of future releases and the current platform offers a robust set of features that streamline ECG workflows and reduce costs for healthcare providers.","length":380,"tagName":"p"},{"type":"text","content":"“I like it… You had me at hello, but you really, you REALLY, had me with the comparisons. That is just outstanding!” — Dr. Matt Fay, Clinical Director of Cardiology, Westcliffe Health Innovations, U.K.","length":202,"tagName":"p","attribs":{}},{"type":"text","content":"MyoVista Insights is the first vendor-agnostic ECG management platform designed to run AI-ECG algorithm models from multiple development partners. It features a unique prioritization system and incorporates a standardized ECG reporting protocol which provides a structured and consistent approach to ECG interpretation. Additionally, it includes display protocols specifically designed to enable patient-centric longitudinal comparisons and help track disease progression over time.","length":482,"tagName":"p"},{"type":"text","content":"“Extremely user-friendly, even for someone who struggles with technology!”—...

More updates from Heartsciences Inc.

HeartSciences Inc.medical technology companyMyoVista InsightsInsightshealthcare providersECGfuture releasesHeartSciencesAI-ECG